US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery: market research reports

RSS Feeds

Drug Discovery market research reports and industry analysis

6  7  8  9    11    13  14  15  
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... the Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD), complete with comparative analysis at various ...  |  read more...
$2,000.00
Epithelial Ovarian Cancer - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Epithelial Ovarian Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Chronic Heart Failure - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Chronic Heart Failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Open-Angle Glaucoma - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Open-Angle Glaucoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Myocardial Ischemia - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Myocardial Ischemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Helicobacter Pylori Infections - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Helicobacter Pylori Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Nasopharyngeal Cancer - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Nasopharyngeal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Brain Metastasis - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Brain Metastasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Ventilator Associated Pneumonia (VAP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
$2,000.00
Pulmonary Hypertension - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Pulmonary Hypertension, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Botulism - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... Botulism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
$2,000.00
Endometrial Cancer - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Endometrial Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Squamous Non-Small Cell Lung Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
$2,000.00
Medulloblastoma - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... Medulloblastoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
$2,000.00
Neurofibromatoses Type II - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Neurofibromatoses Type II, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Respiratory Depression - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Respiratory Depression, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Cirrhosis - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... Cirrhosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
$2,000.00
Hypercholesterolemia - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... Hypercholesterolemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
$2,000.00
Age Related Macular Degeneration - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Age Related Macular Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
$2,000.00
Rheumatoid Arthritis - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Rheumatoid Arthritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,500.00
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), complete with comparative analysis at various stages, therapeutics assessment by ...  |  read more...
$2,000.00
Metastatic Liver Cancer - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Metastatic Liver Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Opioid-Induced Constipation (OIC), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Venous Leg Ulcers (Crural ulcer), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
$2,000.00
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Uterine Leiomyoma (Uterine Fibroids), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
$2,000.00
6  7  8  9    11    13  14  15  
 
Our Clients